BILE DUCT CANCER
Clinical trials for BILE DUCT CANCER explained in plain language.
Never miss a new study
Get alerted when new BILE DUCT CANCER trials appear
Sign up with your email to follow new studies for BILE DUCT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tested the drug pembrolizumab in over 1,600 people with various advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink or control the tumors. The trial focused on identifying which patients were most likel…
Matched conditions: BILE DUCT CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Can a drug combo wake up 'Cold' tumors to immunotherapy?
Disease control TerminatedThis study tests whether combining two drugs (atezolizumab and tivozanib) can help the immune system attack cancers that usually don't respond to immunotherapy, like certain prostate, pancreatic, and breast cancers. About 29 adults with advanced or metastatic disease who have alr…
Matched conditions: BILE DUCT CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New dual-immunotherapy combo tested in advanced cancers
Disease control OngoingThis early-phase study tests a new drug, AI-061, which combines two immunotherapy agents (anti-PD-1 and anti-CTLA-4) into one treatment for people with advanced solid tumors that have stopped responding to standard therapies. The main goal is to find the safest dose and check for…
Matched conditions: BILE DUCT CANCER
Phase: PHASE1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC